Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
eCl@ss:
32160405
UNSPSC Code:
12352200
biological source
human
assay
>98% (SDS-PAGE)
specific activity
≥1 x 10e5 U/mg
manufacturer/tradename
Chemicon®
technique(s)
cell culture | mammalian: suitable
impurities
<0.1 ng/μg Endotoxin (of IGF-1; 1EU/ug)
input
sample type mesenchymal stem cell(s)
sample type hematopoietic stem cell(s)
NCBI accession no.
UniProt accession no.
shipped in
dry ice
Gene Information
human ... IGF1(3479)
General description
Insulin Like Growth Factor-I (IGF-I) is a polypeptide growth factor which stimulates the proliferation of a wide range of cell types including muscle, bone, and cartilage tissue. Human IGF-I is a 7.6 kDa protein containing 70 amino acid residues.
Insulin-like Growth Factor (IGF-1) is a polypeptide endocrine hormone similar in structure to insulin. Stimulated by growth hormone and produced primarily in the liver, it binds to the IGF-1 receptor with a high affinity and to the insulin receptor with a much lower affinity. The tyrosine kinase IGF-1 receptor is a potent activator of the Akt signaling pathway, which drives a variety of processes including cell growth and division and apoptosis inhibition. Because approximately 98% of IGF-1 is always bound to one of six binding proteins (IGF-BP), extraction is required to measure extracellular protein concentrations. Increased levels of IGF-1 have been correlated with an increased risk of cancer. In addition, while involved in reducing hemoglobin A1C levels and daily insulin consumption in types 1 and 2 diabetes, these increased levels have been also implicated in the development of diabetic retinopathy. Drugs have been developed as replacement therapy for severe primary IGF-1 deficiency, a group of diseases in which patients do not respond to growth hormone therapy.
Product Source: E.coli
Application
For most in vitro applications, IGF-I exerts its biological activity in the concentration range of 0.2 to 20.0 ng/mL. Responding cells are (partial list): bone, muscle cells, CHO cells.
Optimal working dilutions must be determined by end user.
Optimal working dilutions must be determined by end user.
Physical form
Lyophilized from sterile filtered 10 mM Sodium Phosphate, pH 6, containing no additives.
Preparation Note
The lyophilized IGF-I, though stable at room temperature, is best stored at -20°C for up to 12 months from date of receipt. After a quick spin, reconstitute with sterile water to a concentration of 0.1-1.0 mg/mL. This solution can be diluted into other buffered solutions and stored at 4°C for one week or at -20°C for future use. Reconstituted IGF-I should be stored in undiluted aliquots at -20°C for up to six months. Avoid repeated freeze/thaw cycles.
Analysis Note
Specific Activity: Human IGF-I is fully biologically active when compared to standards.The ED50 as determined by a cell proliferation assay using FDC-P1 cells is ≤10.0 ng/mL
Other Notes
Replaces: GF006
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage Class
11 - Combustible Solids
wgk
WGK 3
Regulatory Information
监管及禁止进口产品
This item has
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Jai Won Chang et al.
The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology, 26(6), 479-499 (2022-10-28)
The lack of a clonal renin-secreting cell line has greatly hindered the investigation of the regulatory mechanisms of renin secretion at the cellular, biochemical, and molecular levels. In the present study, we investigated whether it was possible to induce phenotypic
Wenjian Gan et al.
Nature cell biology, 22(2), 246-256 (2020-02-06)
The Hippo and mammalian target of rapamycin complex 1 (mTORC1) pathways are the two predominant growth-control pathways that dictate proper organ development. We therefore explored potential crosstalk between these two functionally relevant pathways to coordinate their growth-control functions. We found
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service